| PTLE 0.282 51.53% | SOXS 3.65 11.56% | MSPR 0.664 27.57% | SCNX 0.8182 15.35% | NVDA 198.69 -3.96% | SQQQ 13.79 6.16% | ORIS 0.1603 -0.12% | BYND 1.33 -4.32% | PFE 24.3 -1.46% | HTZ 6.73 36.23% | PLTR 190.74 -7.94% | TSLL 20.34 -10.16% | ETHA 24.28 -10.37% | ASST 1.25 -1.57% | IBIT 57.18 -5.53% | GRAB 5.785 -4.70% | INTC 37.03 -6.25% | PLUG 2.52 -8.36% | ONDS 5.96 -3.09% | OPEN 6.92 -8.83% | CHR 0.136 8.11% | FGL 0.5165 26.94% | DNN 2.74 -6.00% | TSLA 444.26 -5.15% | WTO 0.0497 -6.23% | CAPT 0.6615 31.77% | NFE 1.35 14.41% | SOXL 42.8 -11.90% | BITF 3.84 -6.57% | ETHD 5.26 20.92% | T 24.44 -0.37% | EPWK 0.0748 3.60% | F 12.79 -1.69% | SPY 675.24 -1.19% | SOFI 29.37 -4.11% | KVUE 15.97 -1.05% | ACHR 9.56 -8.25% | CIFR 22.51 -1.10% | QQQ 619.25 -2.03% | HIMS 42.79 -3.60% | GPUS 0.3494 -7.03% | TQQQ 111.08 -6.12% | LQD 110.68 0.14% | BTBT 3.18 -7.02% | AAL 12.65 -5.17% | TZA 8.21 5.26% | BURU 0.29 -7.91% | NCLH 18.79 -15.28% | RGTI 35.18 -10.07% | BTG 4 -5.77%

Freshpet Shares Gain 9% as Q3 Profit Smashes Estimates, Guidance Tightened

Freshpet Inc. (NASDAQ: FRPT) reported third-quarter earnings that far exceeded Wall Street expectations, sending shares up more than 9% in intra-day trading on Monday.

The company posted adjusted earnings of $1.86 per share, dramatically surpassing analyst estimates of $0.43. Revenue rose 14% year-over-year to $288.8 million, beating the consensus forecast of $284.22 million. Growth was driven by a 12.9% increase in volume and a 1.1% favorable price/mix effect.

Freshpet achieved positive free cash flow during the quarter for the first time and now expects to remain free cash flow positive for the full fiscal year 2025, one year earlier than anticipated. Adjusted EBITDA climbed to $54.6 million from $43.5 million in the same quarter last year.

The company updated its full-year 2025 guidance, projecting net sales growth of approximately 13%, down slightly from the prior range of 13% to 16%. It also narrowed its adjusted EBITDA outlook to between $190 million and $195 million from the previous $190 million to $210 million range. Capital expenditure guidance was reduced to about $140 million from $175 million.

Published on: November 3, 2025